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This paper describes the first case of common variable
immunodeficiency (CVID) and AA amyloidosis. A recently
treated tuberculosis, and chronic inflammation induced by
frequent respiratory tract infections, were thought to be respon-
sible for the amyloidosis. No other reason for this condition
could be detected. Although T cell dysfunction in some CVID
patients has been reported, pulmonary tuberculosis is quite rare
with this condition. Bacterial or viral agents or evidence in
favour of intestinal tuberculosis, which would explain this
patient's recurrent diarrhea, were not found. In this case, the
response of the attacks of diarrhea to metranidazole and the
histologic observation of extensive intestinal amyloid deposi-
tion, which is known to decrease intestinal motility, made us
conclude that the diarrhea was associated with bacterial
overgrowth. In this report, we discuss the association of CVID
and tuberculosis to secondary amyloidosis and recurrent
diarrhea.
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INTRODUCTION
Common variable immunodeficiency (CVID) is
a not uncommon disease which usually manifests
in the second or third decade of life with recurrent
bacterial infections and hypoglobulinemia.
1,2
There is surprisingly, a high incidence of gastroin-
testinal diseases and chronic diarrhea, which is
reported in as many as 30% of these patients. A
microbial agent can be identified in fewer than
half the cases and is most likely to be Giardia
lamblia or bacterial overgrowth in the small
bowel.
3 Enteroviral infections may occur but they
are not a major problem. Chronic diarrhea is one
of the most common presentations of the disease
and it can sometimes be quite troublesome.
Although the diarrhea is usually infectious, it may
be associated with Crohn's disease, gluten entero-
pathy, collagenous colitis, achlorhydria and
pernicious anemia.
4-6
Recurrent bacterial infections during the course
of CVID have been reported; however, the devel-
opment of tuberculosis and secondary amyloi-
dosis has not been reported until now. In this
current case, the first patient in the literature with
CVID and amyloidosis, who presented with
recently worsened chronic diarrhea and sepsis, is
described. A rare case of tuberculosis with CVID
and their amyloid relationship is discussed.
CASE REPORT
A 28-year-old male was admitted to our hospi-
tal with a-two-month history of diarrhea, abdomi-
nal pain, weight loss, fever, and fatigue. His medi-
cal history revealed 3 to 5 episodes of diarrhea
each year and recurrent respiratory tract infec-
tions since the age of 14 years old. He had been
succesfully treated for postprimary cavitary pul-
monary tuberculosis (acid-fast bacteria in smears
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of sputum and sputum culture positive for Myco-
bacterium tuberculosis in Lowenstein media) and
had been given isoniazid (300 mg/day), rifampi-
cine (600 mg/day), ethambutol (1.5 g/day) and
pyrazinamide (2 g/day) for 2 months, followed by
isoniazid and rifampicine for 10 more months,
until 2 months prior to his hospitalization. His
condition rapidly deteriorated with the above
mentioned symptoms apparent 2 months after
cessation of antituberculosis therapy.
Physical examination revealed a severely mal-
nourished male with a temperature of 39 ; blood
pressure 100/60 mmHg; and a heart rate of 96/
min. Abdominal examination revealed increased
bowel sounds and slight abdominal tenderness.
Laboratory studies disclosed: hemoglobin, 14.3
g/dL; WBC, 15,600/ L; platelets, 308,000/ L; μ μ
ESR, 60 mm/h; CRP, 41.4 mg/dL (normal 0-5);
total protein, 5.1 g/dL; and albumin, 2.7 g/dL.
Other biochemical data was normal. Urinalysis
revealed 4+ proteinuria with oval fat bodies in the
sediment. Creatinine clearance was 93 mL/min
and proteinuria was 9 g/d. Serum immunoglo-
bulins were as follows: IgG, 168 mg/dL (normal
800- 1700); IgM, 8.95 mg/dL (normal 50-320); IgA,
10.2 mg/dL (normal 85-450); and, IgE, 28.7 IU/mL
(normal 0-100). C3 complement was 54.3 mg/dL
(normal 50-90). Anti-gliadine IgA and IgG were
both negative. CD4/CD8 ratio, CD3, CD56 were
normal and tuberculin skin test was positive (17mm
induration). Neutrophil function tests (chemotaxis,
phagocytosis, oxidative burst) were within normal
limits. Chest X-ray and ECG were normal.
Cultures of blood and urine were negative.
Numerous erythrocytes and leucocytes were seen
in the stool specimen, but stool cultures for
Salmonella, Shigella and Campylobacter were
negative. Toxin A was negative in the stool. Se-
rologies for HIV, HBV, HCV were negative. Anti-
HSV, anti-EBV and anti-CMV IgM's were also
negative.
Thoracic CT revealed old fibrotic scars in the
upper lobes of both lungs, suggesting healed
tuberculosis. Abdominopelvic CT was normal. On
radiologic examination of the small bowel, there
was dilatation and increased mucosal thickness of
valvula conniventes. Gastroduodenoscopy was
normal; multiple biopsies were obtained and duo-
denal aspiration was performed. Rectosigmoi-
doscopy was nondiagnostic. Histologic examina-
tion of esophageal, duodenal, colon (Fig. 1) and
gastric (Fig. 2) biopsies revealed extensive, sub-
epithelial, Congo red positive amyloid deposition.
Disappearance of these after adding KMnO4
suggested AA amyloidosis, also confirmed by im-
munohistochemical staining. In addition, the four
currently identified mutations of MEVF gene on
exon 10, associated with familial Mediterranean
fever (FMF) -which are M694V, M694I, M680I,
V726A,- were negative.
Ciprofloxacine (200 mg, bid, i.v.) and metroni-
dazole (500 mg, bid, i.v.) were commenced. The
patient's clinical condition started to improve
within a few days and returned to normal at 3
weeks. The antibiotics were then discontinued
and the patient was discharged. Two weeks later,
Fig. 2. Extensive amyloid deposition is visible among the
crypts of the lamina propria and in the deep mucosa.
(Congo-red × 200).
Fig. 1. Massive amyloid deposition beneath the surface
epithelium (Congo-red × 200).Association of Secondary Amyloidosis With Common Variable Immune Deficiency and Tuberculosis
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diarrhea with 3-4 bowel movements/day devel-
oped, and repeated diagnostic tests revealed no
specific cause. Metronidazole was recommended
for 3 further months during which the patient's
diarrhea disappeared and he put on 18 kg but
hypogammaglobulinemia and nephrotic-range
proteinuria persisted. Later, colchicine 1.5 mg/day
was administered to hopefully control proteinuria.
At the end of the third year of follow-up; the
patient was still using colchicine and also metro-
nidazole (500 mg, bid, p.o.) for one week every
month or in the case of > 3 mushy stools/day
lasting > 3 days. The control gastroscopy and rec-
tosigmoidoscopy were normal: biopsies showed
AA amyloid infiltration. Although the patient had
hypogammaglobulinemia, his condition did not
worsen except for recurrent upper respiratory
tract infections, a recent acute attack of chronic
otitis media, and chronic recurrent diarrhea. The
patient's creatinine clearance was normal, but the
proteinuria was still in the nephrotic range.
DISCUSSION
Pulmonary tuberculosis in patients with CVID
was reported as a rare entity in the literature.
7
Whether this concurrent disease pairing is just
coincidence or due to a defect in T-cell function
is not clear. Because of the high prevalence of
tuberculosis (0.38%) in the general population in
Turkey (Data from the Ministry of Health, 1992),
we cannot exclude the possibility of coincidence.
T-cell dysfunction may be present in up to half of
CVID cases.
3,8 In this case, although the presence
of tuberculosis might still have been related to a
T-cell functional defect which accompanies CVID,
normal lymphocyte function tests and a positive
tuberculin skin test, suggest no T-cell dysfunction.
Although recurrent infections are common in
CVID,
3,7-9 no other reported case of secondary
amyloidosis accompanying CVID, could be found.
Renal amyloidosis secondary to pulmonary tuber-
culosis is fairly common (3.6-50%).
10,11 In this case,
it is difficult to determine the duration of the
subclinical pulmonary tuberculosis. However, the
development of cavitation suggests that the
patient has had a long period of silent inflamma-
tion which may have been a reason for secondary
amyloidosis. Therefore, although tuberculosis may
not be the only possible cause of amyloidosis in
this case, it is easy to comment on whether other
frequent infections had some additive effect on
the inflammatory response. In Turkey, one of the
possible causes of amyloidosis might have been
FMF, but in our patient there was no history
suggestive of FMF and none of the described FMF
gene mutations were present.
In this case, one possible cause for recurrent
diarrhea may have been intestinal tuberculosis.
Although intestinal tuberculosis accompanies
cavitary tuberculosis and positive sputum smears,
with a much higher incidence than in noncavitary
tuberculosis,
12 worsening of the diarrhea since the
patient's childhood in a continuous fashion 2
months after cessation of antituberculosis therapy,
might prove that tuberculosis was probably not
the cause of the diarrhea. Also, there were no
signs suggestive of intestinal tuberculosis, both
radiologically and endoscopically. Furthermore,
Mycobacterium tuberculosis could not be seen in
direct examination of, and specific cultures of, the
stool.
There is an increased incidence of Crohn's dis-
ease in CVID
13 and this may have been another
cause for this patient's diarrhea. As in intestinal
tuberculosis, amyloidosis secondary to Crohn's
disease is also rare in the literature.
14,15 In this
case, increased mucosal thickness of the valvula
conniventes, visible with a barium meal, were
suggestive of Crohn's disease. However, gastro-
intestinal system biopsies did not reveal any
histologic findings supporting granulomatous
bowel disease.
Viral etiologies for diarrhea were excluded by
negative serology and by the absence of inclusion
bodies in the biopsy specimens. . Also, colchicine,
which was used in this patient, could possibly
cause mild diarrhea. Colchicine was shown to
have promising results in experimental cases of
secondary amyloidosis but it is not that effective
clinically.
16 In this patient however, it was intro-
duced after the onset of diarrhea.
In the case of gastrointestinal amyloidosis, de-
creased gastrointestinal motility causes bacterial
overgrowth, bile acid deconjugation and conse-
quently, diarrhea, steatorrhea and severe malab-
sorption.
17 In this case, another possible cause ofAykut Ferhat Çelık, et al.
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diarrhea is giardiasis frequently seen in CVID.
The resolution of symptoms with oral metroni-
dazole in each attack of diarrhea, suggests that
either bacterial overgrowth or giardiasis were
responsible for the diarrhea. However, giardia
was not seen in stool analysis, duodenal biopsies
or duodenal aspiration which suggests bacterial
overgrowth. In addition, Whipple's disease can
also present with the same symptomology and
responds to broad-spectrum antibiotics but has
frequent recurrence of symptoms. However, the
intestinal biopsy specimens in our case did not
reveal the presence of any PAS positive microoor-
ganisms.
In this case, extensive amyloid infiltration and
incomplete local defences inducing overgrowth
are the probable causes of diarrhea. It is unusual
to see tuberculosis with CVID. However, the coin-
cidence of this occurring, in a country endemic for
tuberculosis, is not surprising. Secondary amyloi-
dosis in this case was most probably due to the
additive effects of tuberculosis and recurrent bac-
terial infections during the course of CVID.
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